Overview

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Determine the role of androgen deprivation therapy in high risk patients receiving 45 Gy of pelvic radiotherapy plus a Pd-103 boost and the impact of the duration of ADT in hormonally-manipulated patients.
Phase:
Phase 3
Details
Lead Sponsor:
Schiffler Cancer Center
Collaborators:
Kent E. Wallner, M.D.
Sylvester, John, M.D.
Treatments:
Bicalutamide
Hormones